Science
Over 1.5 billion people worldwide suffer from chronic pain.
Current treatments are failing.
Scientific
Overview
Our key therapeutic pillar is chronic pain. Chronic pain affects hundreds of millions of people globally with current treatments remaining woefully inadequate often due to limited pain relief or serious side effects and complications with prolonged use.
Relevium Medical focuses on the need for multimodal treatments for specific chronic pain conditions. We treat the core symptom of pain, and other disease-specific symptoms giving superior relief.
Our Approach
We are leveraging biopolymers found abundantly in the body - tailoring these with innovative pharmacological molecules to create novel therapeutic formulations targeting each selected disease. Each formulation is developed to levels of pharmaceutical excellence ensuring superior and safe products.
